Private equity advisory firm Jacob Ballas Capital India has partially exited its investment in India-based active pharmaceutical ingredients and chemicals maker Vivimed Labs, selling an 8 percent stake on the Bombay Stock Exchange. Jacob Ballas, which originally invested through Jacob Ballas India Fund III, sold 6.5 million shares for INR10 (approximately US$0.15) each. Post transaction, Jacob Ballas holds a 5.1 percent stake in the company.